Investors Bet Big on Cancer Drug Infant Duality Biologics and Its Rockstar Founder
Company has raised $120 million in 18 months from A-list investors including Eli Lilly and domestic heavyweight WuXi Biologics Key takeaways Duality Biologics’ new $90 million funding just 18 months…
RELATED ARTICLES
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
HBM gets health boost from drug licensing deals
2142.HK
-
RemeGen hopes for pain relief from expanded drug uses
9995.HK 688331.SHG
-
CStone breaks up with drugs partner as U.S. rollout stalls
2616.HK
-
Missing the Covid boat, Junshi stumbles back to old business
1877.HK 688180.SHG
Discover hidden China stock gems in our weekly newsletter